CEVA vs ELAN
CEVA: CEVA is the leading silicon and software IP provider enabling Physical AI through unified connectivity, sensing, and inference capabilities embedded in billions of edge devices. ELAN: Elanco is a global animal health company providing pharmaceuticals, vaccines, and nutrition solutions for livestock, poultry, and companion animals.
Side-by-side fundamentals
| Metric | CEVA | ELAN | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $40.06 | $25.34 | |
| Market cap as of 2026-07-23 | $1.1B | $12.7B | |
| PEG as of 2026-07-23 | -1.35 | n/a | |
| Net margin as of 2026-07-23 | -10.5% | -5.0% | ELAN higher |
| Gross margin as of 2026-07-23 | +87.2% | +55.1% | CEVA higher |
| Operating margin as of 2026-07-23 | -10.7% | -3.7% | ELAN higher |
| ROE as of 2026-07-23 | -3.9% | -3.6% | ELAN higher |
| ROA as of 2026-07-23 | -3.4% | -1.8% | ELAN higher |
| Debt / equity as of 2026-07-23 | 0.00 | 0.61 | CEVA lower |
| Revenue growth (YoY) as of 2026-07-23 | +3.0% | +10.5% | ELAN higher |
| Revenue CAGR (3y) SEC XBRL | +19.9% | +2.2% | CEVA higher |
| Beta as of 2026-07-23 | 2.00 | 1.72 | |
| 1-year return as of 2026-07-22 close | +70.7% | +73.6% | ELAN higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.